Analysis of FUSOBACTERIUM NUCLEATUM and Streptococcus Gallolyticus in Saliva of Colorectal Cancer Patients

References

• Ferlay J , SoerjomataramI, DikshitRet al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer136(5), E359–E386 (2015).
   PubMed Web of Science ®Google Scholar
• Jasperson KW , TuohyTM, NeklasonDW, BurtRW. Hereditary and familial colon cancer. Gastroenterology138(6), 2044–2058 (2010).
   PubMed Web of Science ®Google Scholar
• Song M , GarrettWS, ChanAT. Nutrients, foods, and colorectal cancer prevention. Gastroenterology148(6), 1244–1260 (2015).
   PubMed Web of Science ®Google Scholar
• Zeller G , TapJ, VoigtAYet al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol. Syst. Biol.10(11), 766 (2014).
   PubMed Web of Science ®Google Scholar
• Oke S , MartinA. Insights into the role of the intestinal microbiota in colon cancer. Ther. Adv. Gastroenterol.10(5), 417–428 (2017).
   PubMed Web of Science ®Google Scholar
• Chen GY . The role of the gut microbiome in colorectal cancer. Clin. Colon Rectal. Surg.31(3), 192–198 (2018).
   PubMed Web of Science ®Google Scholar
• Arthur JC , Perez-ChanonaE, MühlbauerMet al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science338(6103), 120–123 (2012).
   PubMed Web of Science ®Google Scholar
• Kostic AD , ChunE, RobertsonLet al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor immune microenvironment. Cell Host Microbe14(2), 207–215 (2013).
   PubMed Web of Science ®Google Scholar
• Boleij A , MuytjensCMJ, BukhariSIet al. Novel clues on the specific association of Streptococcus gallolyticus subsp gallolyticus with colorectal cancer. J. Infect. Dis.203(8), 1101–1109 (2011).
   PubMed Web of Science ®Google Scholar
• Coleman OI , NunesT. Role of the microbiota in colorectal cancer: updates on microbial associations and therapeutic implications. Biores. Open Access5(1), 279–288 (2016).
   PubMedGoogle Scholar
• Tjalsma H , BoleijA, MarchesiJR, DutilhBE. A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects. Nat. Rev. Microbiol.10(8), 575 (2012).
   PubMed Web of Science ®Google Scholar
• Mima K , NishiharaR, QianZRet al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut65(12), 1973–1980 (2016).
   PubMed Web of Science ®Google Scholar
• Amitay EL , WernerS, VitalMet al. Fusobacterium and colorectal cancer: causal factor or passenger? Results from a large colorectal cancer screening study. Carcinogenesis38(8), 781–788 (2017).
   PubMed Web of Science ®Google Scholar
• Wang T , CaiG, QiuYet al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J.6(2), 320–329 (2012).
   PubMed Web of Science ®Google Scholar
• Wu N , YangX, ZhangRet al. Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb. Ecol.66(2), 462–470 (2013).
   PubMed Web of Science ®Google Scholar
• Bonnet M , BucE, SauvanetPet al. Colonization of the human gut by E. coli and colorectal cancer risk. Clin. Cancer Res.20(4), 859–867 (2014).
   PubMed Web of Science ®Google Scholar
• Weir TL , ManterDK, SheflinAM, BarnettBA, HeubergerAL, RyanEP. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS ONE8(8), e70803 (2013).
   PubMed Web of Science ®Google Scholar
• Abdulamir AS , HafidhRR, BakarFA. Molecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8. Mol. Cancer9, 249 (2010).
   PubMed Web of Science ®Google Scholar
• Gallimidi AB , FischmanS, RevachBet al. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget6(26), 22613–22623 (2015).
   PubMedGoogle Scholar
• Boleij A , van GelderMMHJ, SwinkelsDW, TjalsmaH. Clinical importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin. Infect. Dis.53(9), 870–878 (2011).
   PubMed Web of Science ®Google Scholar
• Dekker JP , LauAF. An update on the Streptococcus bovis group: classification, identification, and disease associations. J. Clin. Microbiol.54(7), 1694–1699 (2016).
   PubMed Web of Science ®Google Scholar
• Flemer B , WarrenRD, BarrettMPet al. The oral microbiota in colorectal cancer is distinctive and predictive. Gut (67(8), 1454–1463 (2017).
   PubMed Web of Science ®Google Scholar
• Acharya A , ChanY, KheurS, JinLJ, WattRM, MattheosN. Salivary microbiome in non-oral disease: a summary of evidence and commentary. Arch. Oral Biol.83, 169–173 (2017).
   PubMed Web of Science ®Google Scholar
• Pihlstrom BL , MichalowiczBS, JohnsonNW. Periodontal diseases. Lancet366(9499), 1809–1820 (2005).
   PubMed Web of Science ®Google Scholar
• Lynch SV , PedersenO. The human intestinal microbiome in health and disease. New Engl. J. Med.375(24), 2369–2379 (2016).
   PubMed Web of Science ®Google Scholar
• Zaura E , BrandtBW, Teixeirade Mattos MJet al. Same exposure but two radically different responses to antibiotics: resilience of the salivary microbiome versus long-term microbial shifts in feces. mBio6(6), e01693–01615 (2015).
   PubMed Web of Science ®Google Scholar
• Rasiah IA , WongL, AndersonSA, SissonsCH. Variation in bacterial DGGE patterns from human saliva: over time, between individuals and in corresponding dental plaque microcosms. Arch. Oral Biol.50(9), 779–787 (2005).
   PubMed Web of Science ®Google Scholar
• Yoshizawa JM , SchaferCA, SchaferJJ, FarrellJJ, PasterBJ, WongDTW. Salivary biomarkers: toward future clinical and diagnostic utilities. Clin. Microbiol. Rev.26(4), 781–791 (2013).
   PubMed Web of Science ®Google Scholar
• Sobhani I , TapJ, Roudot-ThoravalFet al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE6(1), e16393 (2011).
   PubMed Web of Science ®Google Scholar
• Mira-Pascual L , Cabrera-RubioR, OconSet al. Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers. J. Gastroenterol.50(2), 167–179 (2015).
   PubMed Web of Science ®Google Scholar
• Lauritano D , SbordoneL, NardoneM, IapichinoA, ScapoliL, CarinciF. Focus on periodontal disease and colorectal carcinoma. Oral Implantol. (Rome)10(3), 229–233 (2017).
   PubMedGoogle Scholar
• Hajishengallis G . Periodontitis: from microbial immune subversion to systemic inflammation. Nat. Rev. Immunol.15(1), 30–44 (2015).
   PubMed Web of Science ®Google Scholar
• Zhou X , LiuX, LiJ, AprecioRM, ZhangW, LiY. Real-time PCR quantification of six periodontal pathogens in saliva samples from healthy young adults. Clin. Oral Investig.19(4), 937–946 (2015).
   PubMed Web of Science ®Google Scholar
• Mättö J , SaarelaM, AlaluusuaS, OjaV, Jousimies-SomerH, AsikainenS. Detection of Porphyromonas gingivalis from saliva by PCR by using a simple sample-processing method. J. Clin. Microbiol.36(1), 157–160 (1998).
   PubMed Web of Science ®Google Scholar
• Flynn KJ , BaxterNT, SchlossPD. Metabolic and community synergy of oral bacteria in colorectal cancer. mSphere1(3), e00102–00116 (2016).
   PubMed Web of Science ®Google Scholar
• Dejea CM , WickEC, HechenbleiknerEMet al. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc. Natl Acad. Sci. USA111(51), 18321–18326 (2014).
   PubMed Web of Science ®Google Scholar
• Russo E , BacciG, ChielliniCet al. Preliminary comparison of oral and intestinal human microbiota in patients with colorectal cancer: a pilot study. Front. Microbiol.8, 2699 (2017).
   PubMed Web of Science ®Google Scholar
• Chen X , WincklerB, LuMet al. Oral microbiota and risk for esophageal squamous cell carcinoma in a high-risk area of China. PLoS ONE10(12), e0143603 (2015).
   PubMed Web of Science ®Google Scholar
• Xu Y , TengF, HuangSet al. Changes of saliva microbiota in nasopharyngeal carcinoma patients under chemoradiation therapy. Arch. Oral Biol.59(2), 176–186 (2014).
   PubMed Web of Science ®Google Scholar
• Farrell JJ , ZhangL, ZhouHet al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut61(4), 582–588 (2012).
   PubMed Web of Science ®Google Scholar
• Hwang IM , SunLM, LinCL, LeeCF, KaoCH. Periodontal disease with treatment reduces subsequent cancer risks. QJM107(10), 805–812 (2014).
   PubMed Web of Science ®Google Scholar
• Liong M-T . Roles of probiotics and prebiotics in colon cancer prevention: postulated mechanisms and in-vivo evidence. Int. J. Mol, Sci.9(5), 854–863 (2008).
   PubMed Web of Science ®Google Scholar
• Mima K , CaoY, ChanATet al. Fusobacterium nucleatum in colorectal carcinoma tissue according to tumor location. Clin. Transl. Gastroenterol.7(11), e200 (2016).
   PubMedGoogle Scholar
• Sears CL , GarrettWS. Microbes, microbiota and colon cancer. Cell Host Microbe15(3), 317–328 (2014).
   PubMed Web of Science ®Google Scholar
• Gur C , IbrahimY, IsaacsonBet al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity42(2), 344–355 (2015).
   PubMed Web of Science ®Google Scholar
• Yu T , GuoF, YuYet al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell170(3), 548–563.e516 (2017).
   PubMed Web of Science ®Google Scholar
• McCoy AN , Araújo-PérezF, Azcárate-PerilA, YehJJ, SandlerRS, KekuTO. Fusobacterium is associated with colorectal adenomas. PLoS ONE8(1), e53653 (2013).
   PubMed Web of Science ®Google Scholar
• Ahn J , SinhaR, PeiZet al. Human gut microbiome and risk for colorectal cancer. J. Natl Cancer Inst.105(24), 1907–1911 (2013).
   PubMedGoogle Scholar
• Flanagan L , SchmidJ, EbertMet al. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome. Eur. J. Clin. Microbiol. Infect. Dis.33(8), 1381–1390 (2014).
   PubMed Web of Science ®Google Scholar
• Bullman S , PedamalluCS, SicinskaEet al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science358(6369), 1443 (2017).
   PubMed Web of Science ®Google Scholar
• Kato I , VasquezAA, MoyerbraileanGet al. Oral microbiome and history of smoking and colorectal cancer. J. Epidemiol. Res.2(2), 92–101 (2016).
   PubMedGoogle Scholar
• Hall MW , SinghN, NgKFet al. Inter-personal diversity and temporal dynamics of dental, tongue, and salivary microbiota in the healthy oral cavity. NPJ Biofilms Microbiom.3(1), 2 (2017).
   PubMedGoogle Scholar
• Topcuoglu N , PalturaC, KulekciM, UstekD, KulekciG. Real-time polymerase chain reaction versus conventional PCR: a comparison between two methods for the detection of Fusobacterium nucleatum in saliva, nasopharyngeal secretion and middle ear effusion samples. Biotechnol. Biotechnological Equip.27(3), 3825–3828 (2013).
   Web of Science ®Google Scholar
• Ito M , KannoS, NoshoKet al. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway. Int. J. Cancer137(6), 1258–1268 (2015).
   PubMed Web of Science ®Google Scholar
• Krishnan S , EslickGD. Streptococcus bovis infection and colorectal neoplasia: a meta-analysis. Colorect. Dis.16(9), 672–680 (2014).
   PubMed Web of Science ®Google Scholar
• Butt J , JenabM, Willhauck-FleckensteinMet al. Prospective evaluation of antibody response to Streptococcus gallolyticus and risk of colorectal cancer. Int. J. Cancer0(0), (2018).
   Google Scholar
• Kumar R , HeroldJL, TaylorJ, XuJ, XuY. Variations among Streptococcus gallolyticus subsp. gallolyticus strains in connection with colorectal cancer. Sci. Rep.8, 1514 (2018).
   PubMed Web of Science ®Google Scholar
• Kumar R , HeroldJL, SchadyDet al. Streptococcus gallolyticus subsp. gallolyticus promotes colorectal tumor development. PLoS Pathogens13(7), e1006440 (2017).
   PubMed Web of Science ®Google Scholar
• Aymeric L , DonnadieuF, MuletCet al. Colorectal cancer specific conditions promote Streptococcus gallolyticus gut colonization. Proc. Natl Acad. Sci. USA115(2), E283–E291 (2018).
   PubMed Web of Science ®Google Scholar
• Andres-Franch M , GalianaA, Sanchez-HellinVet al. Streptococcus gallolyticus infection in colorectal cancer and association with biological and clinical factors. PLoS One12(3), e0174305 (2017).
   PubMed Web of Science ®Google Scholar
• Klein RS , ReccoRA, CatalanoMT, EdbergSC, CaseyJI, SteigbigelNH. Association of Streptococcus bovis with carcinoma of the colon. New Engl. J. Med.297(15), 800–802 (1977).
   PubMed Web of Science ®Google Scholar
• Perera M , Al-HebshiNN, SpeicherDJ, PereraI, JohnsonNW. Emerging role of bacteria in oral carcinogenesis: a review with special reference to perio-pathogenic bacteria. J. Oral Microbiol.8(1), 32762 (2016).
   PubMed Web of Science ®Google Scholar
• Lin FY , HuangCY, LuHYet al. The GroEL protein of Porphyromonas gingivalis accelerates tumor growth by enhancing endothelial progenitor cell function and neovascularization. Mol. Oral Microbiol.30(3), 198–216 (2015).
   PubMed Web of Science ®Google Scholar
• Fan X , AlekseyenkoAV, WuJet al. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Gut67(1), 120 (2018).
   PubMed Web of Science ®Google Scholar
• Ren HG , LuuHN, CaiHet al. Oral health and risk of colorectal cancer: results from three cohort studies and a meta-analysis. Ann. Oncol.27(7), 1329–1336 (2016).
   PubMed Web of Science ®Google Scholar
• Rheu GB , JiS, RyuJJet al. Risk assessment for clinical attachment loss of periodontal tissue in Korean adults. J. Adv. Prosthodont.3(1), 25–32 (2011).
   PubMed Web of Science ®Google Scholar
• Miyazaki H , HanadaN, AndohMIet al. Periodontal disease prevalence in different age groups in Japan as assessed according to the CPITN. Community Dent. Oral Epidemiol.17(2), 71–74 (1989).
   PubMed Web of Science ®Google Scholar
• Tan WJ , NgNZ, ChenYDet al. Synchronous polypectomy during endoscopic diagnosis of colorectal cancer – is the risk of tumour implantation at the polypectomy site significant? BMC Gastroenterol. 18(1), 133 (2018).
   PubMedGoogle Scholar
• Solakoglu T , AtalayR, KoseogluHet al. Analysis of 2222 colorectal polyps in 896 patients: a tertiary referral hospital study. Turk. J. Gastroenterol.25(2), 175–179 (2014).
   PubMed Web of Science ®Google Scholar